Search tool

Displaying 131 - 140 of 996

MT-45 molecule

4,4'-DMAR and MT-45 to be placed under control across the EU

Europe has responded to rising concerns over the use of two new drugs by subjecting them to ‘control measures and criminal penalties’ throughout the Union. The implementing decision of the Council of...

Small cover

Report on the risk assessment of 4,4′-DMAR in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on 4,4’-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of...

Small cover

Report on the risk assessment of MT-45 in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part...

Wastewaters

EMCDDA co-hosts ‘Testing the waters 2015’

The EU drugs agency (EMCDDA) is co-hosting next week in Ascona, Switzerland, the second international conference on wastewater analysis: ‘Testing the waters 2015’. The event, to be held from 11–15 October, is...

Publication's cover

20 years: Monitoring, Communicating evidence, Informing policy

In 2015, the EMCDDA commemorates 20 years of monitoring the drugs problem in Europe. This brochure provides a summary of the agency’s key achievements over the period, along with a timeline showing...

Publication's cover

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP)

In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as α-pyrrolidinovalerophenone (α-PVP), through a joint assessment. The two organisations concluded that sufficient...

Poster thumbnail

Ageing and addiction: challenges for treatment systems (poster)

Historically, problem opioid users, mainly injectors, have always represented the largest client group receiving specialised drug treatment in the European Union. The needs of large cohorts that started heroin injecting during the...

Cannabis: what does the data tell us? (poster)

Cannabis is the illicit drug most likely to be used by all age groups. The drug is generally smoked and, in Europe, is commonly mixed with tobacco. Patterns of cannabis use can...

Poster thumbnail

Drug-related deaths indicator (poster)

Drug use, in particular high-risk drug use, is one of the major causes of avoidable mortality among young people in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence...

Poster thumbnail

Drug-related infectious diseases indicator (poster)

Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections amongpeople who inject drugs. This group is...